09606.HK
Duality Biotherapeutics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 197.50
+7.75%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 9.40x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.59x
- Price / sales
- 13.07x
- Price / cash flow
- -27.85x
Enterprise value
- Enterprise value
- HKD 9.8B
- EV / sales
- 9.91x
- EV / EBITDA
- -5.44x
- EV / EBIT
- -5.35x
- Market cap
- HKD 12.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026